Have questions about BPC-157 ?

Text us: 303-204-2469 720-499-6468

Out of stock

BPC-157

Recovery Compound

Quantity

packs

1 vial
2 vial
3 vial
4 vial

Variance

10mg

Clear

Title

Discount

Buy 1

0%

Buy 2

3%

Buy 3

5%

Buy 4

10%

Research Use Only

These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.

What is BPC-157?

BPC-157 is a synthetic peptide sequence derived from a gastric protein fragment. In research settings, it is investigated for its interactions with angiogenic and inflammatory pathways, making it a subject of interest in studies on cellular response and recovery models.

Frequently asked questions

Products from DTC do not include usage instructions, as they are strictly for in vitro research and are prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.

Each vial contains exactly the amount listed on the label. For example, a 10 mg vial contains precisely 10 mg of lyophilized peptide. Researchers may divide the contents into smaller measured portions—such as four 2.5 mg samples—but the total quantity in the vial remains 10 mg.

Peptides from DTC Labs are supplied as lyophilized powder. They do not come reconstituted, and any extra supplies must be sourced separately for research applications.

In lyophilized powder form, peptides remain stable for up to two years. Once reconstituted, they should be refrigerated and are generally stable for up to two months.

Made in the USA

Quality controlled from start to finish. No outsourcing.

Need Help?

Send us a message.

BPC-157 Overview

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide composed of 15 amino acids. It was originally derived from a naturally occurring protein fragment identified in gastric tissue. Since its discovery in the early 1990s, BPC-157 has been studied extensively in laboratory and animal models for its potential influence on cellular protection, structural repair, and angiogenic processes.

Sikiric P. et al. (1993).

History

The peptide was first synthesized by researchers investigating cytoprotective proteins found in gastric juice. Early experiments focused on its ability to support structural integrity in gastrointestinal models. Over time, studies broadened into musculoskeletal, vascular, and dermal systems, where BPC-157 consistently demonstrated properties of interest in the context of tissue regeneration and biological resilience.

Pflaum, M., & Ručman, R. (2005).

BPC-157 Structure

CAS #: 137525-51-0

Molecular Formula: C₆₂H₉₈N₁₆O₂₂

Molecular Weight: 1419.556 g/mol

PubChem ID: 108101

Research Findings

BPC-157 has been studied in structural, vascular, dermatological, and systemic models, with reports of activity in collagen regulation, extracellular matrix remodeling, angiogenesis, and wound closure. Research also highlights protective roles in preclinical systems, supporting cellular integrity and recovery processes.

Key Areas of Research:

• Structural: Collagen, matrix, tendon

• Vascular: Angiogenesis, nitric oxide, repair

• Dermatological: Wound closure, vessel growth, cells

• Systemic: Protection, viability, recovery

Together, these findings suggest broad experimental utility for BPC-157 across multiple biological pathways. Its activity in structural, vascular, dermatological, and systemic models provides a foundation for exploring diverse aspects of regenerative biology. By influencing processes such as collagen regulation, vascular growth, and cellular protection, BPC-157 offers a versatile platform for research into tissue repair, recovery, and systemic resilience within experimental settings.

Sikiric P. et al., Current Pharmaceutical Design, 2020